Abstract
Extracellular nucleotides ATP, ADP, AMP and adenosine are well known signaling molecules of the cardiovascular system that are involved in several physiological processes: cell proliferation, platelet aggregation, inflammatory processes and vascular tonus. The levels of these molecules are controlled by ecto-NTPDases and ecto-5′-nucleotidase/CD73 (ecto-5′-NT/CD73) actions, which are responsible for the complete ATP degradation to adenosine. The thyroid hormones, thyroxine (T4) and triiodothyronine (T3), play important roles in the vascular system promoting vasodilatation. Here we investigated the influence of thyroid hormones on the enzyme cascade that catalyzes the interconversion of purine nucleotides in vascular smooth muscle cells (VSMC). Exposure of VSMCs to 50nM T3 or T4 did not change ATP and ADP hydrolysis significantly. However, the same treatment caused an increase of 75% in AMP hydrolysis, which was time-dependent but dose-independent. Moreover, T3 treatment significantly increased ecto-5′-NT/CD73 mRNA expression, which suggests a genomic effect of this hormone upon ecto-5′-NT/CD73. In addition to the importance of the ecto-5′-NT in cell proliferation and differentiation, its overexpression could result in higher extracellular levels of adenosine, an important local vasodilatator molecule.
Similar content being viewed by others
References
Burnstock G, Sneddon P: Evidence for ATP and noradrenaline as cotransmitters in sympathetic neves. Clin Sci 68 (10): 89–92, 1985
Born GV, Kratzer MA: Source and concentration of extracellular adenosine triphosphate during haemostasis in rats, rabbits and man. J Physiol (London) 354: 419–429, 1984
Gordon JL: Extracellular ATP: Effects, sources and fate. Biochem J 233: 309–319, 1986
Erlinge D. Extracellular ATP: A growth factor for vascular smooth muscle cells. Gen Pharmacol 31: 1–8, 1998
Kitakaze M, Hori M: It is time to ask what adenosine can do for cardioprotection. Heart Vessels 13(5): 211–228, 1998
Mubagwa K, Flameng W: Adenosine, adenosine receptors and myocardial protection: An updated overview. Cardiovasc Res 52: 25–39, 2001
Zimmermann H: 5′-Nucleotidase: Molecular structure and functional aspects. Biochem J 285: 345–365, 1992
Airas L, Hellman J, Salmi M, Bono P, Puurunen T, Smith DJ, Jalkanen S: CD73 is involved in lymphocyte binding to the endothelium: Characterization lymphocyte-vascular adhesion protein-2 identifies it as CD73. J Exp Med 182: 1603–1608, 1995
Stochaj U, Mannherz HG: Chicken gizzard 5′-nucleotidase functions as a binding protein for laminin/nidogen complex. Eur J Cell Biol 59: 364–372, 1992
Turnay J, Olmo N, Risse G, von der Mark K, Lizarbe MA: 5′-Nucleotidase activity in cultured cell lines. Effect of different assay conditions and correlation with cell proliferation. In Vitro Cell Dev Biol 25: 1055–1061, 1989
Nunes MT: Thyroid hormones: Mechanisms of action and biological significance. Arq Bras Endocrinol Metab 47: 639–643, 2003
Muñoz A, Bernal J: Biological activities of thyroid hormone receptors. Eur J Endocrinol 137: 433–445, 1997
Davis PJ, Davis FB: Non-genomic actions of thyroid hormones. Thyroid 6 (5): 497–504, 1996
Klein I, Ojamaa K: Thyroid hormone and the cardiovascular system. New Engl J Med 344: 501–509, 2001
Levey GS, Klein I: Catecholamine-thyroid hormone interactions and cardiovascular manifestations of hyperthyroidism. Am J Med 88: 642–646, 1990
Balkman C, Ojamaa K, Klein I: Time course of the in vivo effects of thyroid hormone on cardiac gene expression. Endocrinology 130: 2001–2006, 1992
Rohrer D, Dillmann WH: Thyroid hormone markedly increases the mRNA coding for saroplasmic reticulum Ca2+-ATPase in the rat heart. J Biol Chem 263: 6941–6944, 1988
Mizuma H, Murakami M, Mori M: Thyroid hormone activation in human vascular smooth muscle cells: Expression of type II iodothyronine deiodinase. Circ Res 88: 313–318, 2001
Ojamaa K, Klemperer JD, Klein I: Acute effects of thyroid hormone on vascular smooth muscle. Thyroid 6: 505–512, 1996
Bruno AN, Fontella FU, Crema LM, Bonan CD, Dalmaz C, Barreto-Chaves MLM, Sarkis JJF: Hyperthyroidism changes nociceptive response and ecto-nucleotidase activities in synaptosomes from spinal cord of rats in different phases of development. Comp Biochem Physiol A Mol Integr Physiol. 140:111–116, 2005
Chan KM, Delfert D, Junger KD: A direct colorimetric assay for Ca2+ -stimulated ATPase activity. Anal Biochem 157: 375–380, 1986
Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254, 1976
Carneiro-Ramos MS, Da Silva VB, Coutinho MBJr, Batasttini AMO, Sarkis JJF, Barreto-Chaves MLM: Thyroid hormone stimulates 5′-ecto-nucleotidase of neonatal rat ventricular myocytes. Mol Cell Biochem 265:195–201, 2004
Yusta B, Ortiz-Caro J, Pascual A, Aranda A: Mechanism of L-triiodothyronine (T3) uptake by glial C6 cells: regulation by butyrate. Mol Cell Endocrinol 58: 191–198, 1988
Hansen KR, Resta R, Webb CF, Thompson LF: Isolation and characterization of the promoter of the human 5′-nucleotidase (CD73)-encoding gene. Gene 167: 307–312, 1995
Kim MK, Lee JS, Chung JH: In vivo transcription factor recruitment during thyroid hormone receptor-mediated activation. Proc Natl Acad Sci 96: 10092–10097, 1999
Spychala J, Zimmermann AG, Mitchell BS: Tissue-especific regulation of the ecto-5′-nucleotidase promoter – Role of the cAMP response element site in mediating repression by the upstream regulatory region. J Biol Chem 274: 22705–22712, 1999
Hoey T, Weinzierl RO, Gill G, Chen JL, Dynlacht BD, Tijan R: Molecular cloning and functional analysis of Drosophila TAF110 reveal properties expected of coactivators. Cell 72: 247–260, 1993
Chen JL, Attardi LD, Verrijzer CP, Yokomori K, Tijan R: Assembly of recombinant TFIID reveals differential coactivator requirements for distinct transcriptional activators. Cell 79: 93–105, 1994
Wink MR, Tamajusuku ASK, Braganhol E, Casali EA, Barreto-Chaves MLM, Sarkis JJF, Battastini AMO: Thyroid hormone upregulates ecto-5′-nucleotidase/CD73 in C6 rat glioma cells. Mol Cell Endocrinol 205: 107–114, 2003
Pearson JD, Carleton JS, Gordon JL: Metabolism of adenine nucleotides by ectoenzymes of vascular endothelial and smooth-muscle cells in culture. Biochem J 190: 421–429, 1980
Rongen GA, Floras JS, Lenders JW, Thien T, Smits P: Cardiovascular pharmacology of purines. Clin Sci 92: 13–24, 1997
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tamajusuku, A.S.K., Carrillo-Sepúlveda, M.A., Braganhol, E. et al. Activity and expression of ecto-5′-nucleotidase/CD73 are increased by thyroid hormones in vascular smooth muscle cells. Mol Cell Biochem 289, 65–72 (2006). https://doi.org/10.1007/s11010-006-9148-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-006-9148-0